19 results
PRE 14A
STOK
Stoke Therapeutics Inc
17 Apr 23
Preliminary proxy
4:01pm
) and issuing a report thereon. The Audit Committee’s responsibility is to monitor and oversee these processes.
In connection with these responsibilities
10-K
1190 khlcmvcm
23 Mar 20
Annual report
4:02pm
424B4
yslr z1s9tq4mw8k
19 Jun 19
Prospectus supplement with pricing info
4:16pm
S-1/A
04njsyi53rhbq1zoi
7 Jun 19
IPO registration (amended)
6:08am
S-1
EX-10.5
eqx dif64c
23 May 19
IPO registration
4:02pm
S-1
49clw9pcbwbf utt
23 May 19
IPO registration
4:02pm
DRS/A
9duru
30 Apr 19
Draft registration statement (amended)
12:00am
DRS
oxrh7a80kp9w0v
26 Mar 19
Draft registration statement
12:00am
- Prev
- 1
- Next